CLINICAL_TRIALS
trial_result
· 2012-05-07
Clinical Trial Update: Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM) [Phase 2]
Summary
Phase 2 clinical trial of intranasal fentanyl for breakthrough pain in cancer patients has completed (FT-017-IM).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nycomed | Conditions: Cancer, Pain | Phase 2 | Status: COMPLETED